PMID- 17166355 OWN - NLM STAT- MEDLINE DCOM- 20110606 LR - 20061214 IS - 1003-0603 (Print) IS - 1003-0603 (Linking) VI - 18 IP - 12 DP - 2006 Dec TI - [Effect of high volume hemofiltration on pulmonary surfactant protein in endotoxin induced acute lung injury in dog]. PG - 737-9 AB - OBJECTIVE: To explore the effect of high volume hemofiltration (HVHF) on pulmonary surfactant protein (SP) in endotoxin induced acute lung injury (ALI) in dogs. METHODS: Sixteen healthy male mongrel dogs were given lipopolysaccharide(LPS 650 mug/kg) via central vein within 30 minutes. After the reproduction of the model, they were divided into two groups randomly (n=8). One group received the treatment of HVHF and mechanical ventilation (MV, treatment group), while another received only MV (model group). Parameters of arterial blood gas and respiratory mechanics were recorded at basic values, after reproduction of the experimental model, and 1, 2 and 4 hours after HVHF. Content of SP-B in lung tissue homogenate was measured by protein Western blot. RESULTS: After injection of LPS, partial pressure of oxygen in artery (PaO(2)) and PaO(2)/fractional concentration of inspired oxygen (FiO(2)) began to decrease (both P<0.05). PaO(2)/FiO(2) <300 mm Hg (1 mm Hg=0.133 kPa) when ALI was reproduced. PaO(2) and PaO(2)/FiO(2) were higher in treatment group than those in model group 4 hours after HVHF (both P<0.01). Inspiratory resistance of airway (Raw) and peak inspiratory pressure (PIP) in model group were kept stable after MV. Lung dynamic compliance (Cdyn) and lung total compliance (Ctot) in model group were both decreased while ventilatory work of breathing (WOBvent) increased 4 hours after MV (all P<0.01). All parameters in the treatment group were kept stable and differences in Cdyn and Ctot were significant at 4 hours after HVHF compared to model group (P<0.01 and P<0.05). Content of SP-B in lung tissue homogenate was significantly higher in treatment group than that in model group (P<0.01). CONCLUSION: HVHF could effectively increase the content of SP-B in lung to prevent aggravation of respiratory mechanics and improve oxygenation. FAU - Zeng, Zhen-guo AU - Zeng ZG AD - Intensive Care Unit,the First Hospital Affiliated to Nanchang University, Nanchang 330006, Jiangxi, China. FAU - Liu, Fen AU - Liu F FAU - Jiang, Rong AU - Jiang R FAU - Zhu, Feng AU - Zhu F FAU - Nie, Cheng AU - Nie C FAU - Qian, Ke-jian AU - Qian KJ LA - chi PT - English Abstract PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - China TA - Zhongguo Wei Zhong Bing Ji Jiu Yi Xue JT - Zhongguo wei zhong bing ji jiu yi xue = Chinese critical care medicine = Zhongguo weizhongbing jijiuyixue JID - 9887521 RN - 0 (Lipopolysaccharides) RN - 0 (Pulmonary Surfactant-Associated Protein B) SB - IM MH - Acute Lung Injury/chemically induced/*metabolism/therapy MH - Animals MH - Disease Models, Animal MH - Dogs MH - *Hemofiltration MH - Lipopolysaccharides/toxicity MH - Lung/metabolism MH - Male MH - Pulmonary Surfactant-Associated Protein B/*metabolism EDAT- 2006/12/15 09:00 MHDA- 2011/06/07 06:00 CRDT- 2006/12/15 09:00 PHST- 2006/12/15 09:00 [pubmed] PHST- 2011/06/07 06:00 [medline] PHST- 2006/12/15 09:00 [entrez] PST - ppublish SO - Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 2006 Dec;18(12):737-9.